Clinical Trials Sponsored by Instituto Nacional de Cancerologia de Mexico

Conditions: Radiation Pneumonitis

Conditions: Promyelocytic Leukemia, Acute

Conditions: Major Depressive Disorder; Advanced Cancer

Conditions: Sars-CoV2

Conditions: Phase II Clinical Trial; Ninety-six Histologically Confirmed NSCLC Patients With BM; Randomized 1:1 to Received TN Plus WBR or Only WBR; ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Conditions: Locally Advanced Malignant Neoplasm

Conditions: ALK Gene Rearrangement Positive; Non-Squamous Non-Small Cell Neoplasm of Lung

Conditions: Breast Neoplasm; Antineoplastic Agents; Antiemetics; Quality of Life

Conditions: HPEC; Ovarian Cancer; Women's Health: Neoplasm of Ovary; Chemotherapy Effect

Conditions: Non-Small Cell Adenocarcinoma; Tyrosine Kinase Mutation; EGFR Gene Mutation

Conditions: Advanced Malignant Pleural Mesothelioma

Conditions: Pulmonary Rehabilitation; Sarcopenia; Quality of Life

Conditions: Carcinoma, Non-Small-Cell Lung; Synchronous Neoplasms

Conditions: Non-Small Cell Lung Cancer; Anorexia; Cachexia; Weight Lose

Conditions: Non-Small Cell Lung Cancer

Conditions: Lung Cancer; Sarcopenia; Toxicity

Conditions: Radiation; Adverse Effect, Pneumonitis

Conditions: Carcinoma, Non-Small-Cell Lung

Conditions: Critically Ill; Cancer

Conditions: Lung Cancer

Conditions: Brain Metastasis

Conditions: Skin Rash; Lung Cancer

Conditions: Non Small-cell Lung Cancer

Conditions: Lung Neoplasms

Conditions: Lung Cancer